Cargando…

Acquired palbociclib resistance in KRAS-mutant lung cancer

Detalles Bibliográficos
Autor principal: Sherr, Charles J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132350/
https://www.ncbi.nlm.nih.gov/pubmed/30214680
http://dx.doi.org/10.18632/oncotarget.26027
_version_ 1783354301616226304
author Sherr, Charles J.
author_facet Sherr, Charles J.
author_sort Sherr, Charles J.
collection PubMed
description
format Online
Article
Text
id pubmed-6132350
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-61323502018-09-13 Acquired palbociclib resistance in KRAS-mutant lung cancer Sherr, Charles J. Oncotarget News Impact Journals LLC 2018-08-28 /pmc/articles/PMC6132350/ /pubmed/30214680 http://dx.doi.org/10.18632/oncotarget.26027 Text en Copyright: © 2018 Sherr et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Sherr, Charles J.
Acquired palbociclib resistance in KRAS-mutant lung cancer
title Acquired palbociclib resistance in KRAS-mutant lung cancer
title_full Acquired palbociclib resistance in KRAS-mutant lung cancer
title_fullStr Acquired palbociclib resistance in KRAS-mutant lung cancer
title_full_unstemmed Acquired palbociclib resistance in KRAS-mutant lung cancer
title_short Acquired palbociclib resistance in KRAS-mutant lung cancer
title_sort acquired palbociclib resistance in kras-mutant lung cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132350/
https://www.ncbi.nlm.nih.gov/pubmed/30214680
http://dx.doi.org/10.18632/oncotarget.26027
work_keys_str_mv AT sherrcharlesj acquiredpalbociclibresistanceinkrasmutantlungcancer